COST-EFFECTIVENESS OF SABR IN OLIGOMETASTATIC CANCER: AN ECONOMIC ANALYSIS BASED ON LONG-TERM RESULTS OF THE SABR-COMET RANDOMIZED TRIAL

RADIOTHERAPY AND ONCOLOGY(2021)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要